The decade's top 10 patent losses, worth a whopping $915B in lifetime sales

Fierce Pharma ------- A decade in the biopharma world has a way of featuring some megablockbuster patent losses, often forcing top drugmakers to fight off cheaper competition as discounted generics rush to steal share. And the last 10 years have taken that pattern to new—even record-setting—heights. Together, the 10 biggest drugs losing IP protections since 2007 will account for more than $915 billion in lifetime sales, according to data compiled by life science commercial intelligence firm Evaluate. The top drug is the biggest patent expiration of all time at a mind-blowing $179 billion, according to the analysts, but that doesn't mean it'll quickly face competition. To learn more click on the picture below to read the article.